Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a ...
Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Nova (NasdaqGS:NVMI) with a Overweight ...
Cantor Fitzgerald initiated coverage of Nova (NVMI) with an Overweight rating and $275 price target Stay Ahead of the Market:Discover ...
We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...
Cantor Fitzgerald initiated coverage of Camtek (CAMT) with a Neutral rating and $100 price target Stay Ahead of the Market:Discover ...
Stock analysts at Cantor Fitzgerald dropped their FY2024 earnings per share estimates for Maplebear in a research note issued on Tuesday, January 7th. Cantor Fitzgerald analyst D. Mathivanan now ...
In a recent blog post, OpenAI CEO Sam Altman said that as OpenAI continues to advance it has moved beyond research to product ...
Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering ...
We recently compiled a list of the 13 AI News and Ratings on Wall Street's Radar. In this article, we are going to take a look at where Varonis Systems, Inc. (NASDAQ:VRNS) stands against the other ...
Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a Overweight recommendation. As of December 23, 2024, the average one ...